-+ 0.00%
-+ 0.00%
-+ 0.00%

REPLIGEN CORP: IF DEAL TERMINATED UNDER SOME CIRCUMSTANCES, BIOLIFE MAY BE REQUIRED TO PAY REPLIGEN A TERMINATION FEE OF $59 MLN

Reuters·07/22/2026 13:00:01

Please log in to view news